skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
84 Trial in progress: a phase 2/3 study of navtemadlin as maintenance therapy in patients with advanced or recurrent endometrial cancer (EC) who responded to chemotherapy (ENGOT-En21 and GOG-3089)
84 Trial in progress: a phase 2/3 study of navtemadlin as maintenance therapy in patients with advanced or recurrent endometrial cancer (EC) who responded to chemotherapy (ENGOT-En21 and GOG-3089)
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

84 Trial in progress: a phase 2/3 study of navtemadlin as maintenance therapy in patients with advanced or recurrent endometrial cancer (EC) who responded to chemotherapy (ENGOT-En21 and GOG-3089)

Concin, Nicole ; De Giorgi, Ugo ; Toon Van Gorp ; Alexandre, Jérôme ; Lindemann, Kristina ; Marth, Christian ; Berger, Regina ; Cibula, David ; Quindós, María ; Bologna, Alessandra ; Korach, Jacob ; Papadimitriou, Christos ; Nicum, Shibani ; Collins, Dearbhaile ; Myers, Reg ; Rothbaum, Wayne ; Herzog, Thomas J ; Monk, Bradley J ; Noelle Gillette Cloven

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A408-A408 [Periódico revisado por pares]

Oxford: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
2
1008 Cross-species characterization of splenic natural killer (NK) cells reveals organ-specific heterogeneity with implications for cancer immunotherapy
1008 Cross-species characterization of splenic natural killer (NK) cells reveals organ-specific heterogeneity with implications for cancer immunotherapy
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

1008 Cross-species characterization of splenic natural killer (NK) cells reveals organ-specific heterogeneity with implications for cancer immunotherapy

Khurshid Iranpur ; Aryana Razmara ; Cruz, Sylvia ; Lammers, Marshall ; Sholevar, Cyrus ; Rebhun, Robert ; Kent, Michael ; Culp, William ; Bold, Richard ; Judge, Sean ; Murphy, William ; Canter, Robert ; Farley, Lauren

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1050-A1050 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
3
444 Genomic and functional characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer
444 Genomic and functional characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

444 Genomic and functional characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer

Cunnea, Paula ; Curry, Ed ; Christie, Elizabeth ; Nixon, Katherine ; Kwok, Chun Hei ; Ploski, Jennifer ; Wulandari, Ratri ; Bowtell, David ; Fotopoulou, Christina

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A98-A99 [Periódico revisado por pares]

Oxford: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
POS1038 NAD+ BOOSTERS AS A NOVEL ANTI-INFLAMMATORY TOOL IN RHEUMATOID ARTHRITIS PATIENTS
POS1038 NAD+ BOOSTERS AS A NOVEL ANTI-INFLAMMATORY TOOL IN RHEUMATOID ARTHRITIS PATIENTS
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

POS1038 NAD+ BOOSTERS AS A NOVEL ANTI-INFLAMMATORY TOOL IN RHEUMATOID ARTHRITIS PATIENTS

Perez-Sanchez, C ; A Escudero Contreras ; Cerdó, T ; Muñoz-Barrera, L ; I Arias de la Rosa ; Sanchez-Pareja, I ; Mendoza, L Marina ; Puerto, N Barbarroja ; Ábalos-Aguilera, M C ; Ruiz, D ; Moreno, J ; Burón, M I ; González-Reyes, J A ; Pilar, F U ; Rojas-Giménez, M ; Calvo, J ; E Collantes Estevez ; Villalba, J M ; Lopez-Pedrera, C

Annals of the rheumatic diseases, 2023, Vol.82 (Suppl 1), p.836-837 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
5
494 CO-1: A novel potent dual function anti-CD47 antibody for cancer therapy
494 CO-1: A novel potent dual function anti-CD47 antibody for cancer therapy
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

494 CO-1: A novel potent dual function anti-CD47 antibody for cancer therapy

Matar, Sittana ; Skah, Seham ; Pettersen, Rolf ; Hestdal, Kjetil ; Richartz, Nina

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A515-A515 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
6
520 PD-1 Inhibits Bystander T Cell Activation and Protects from Activation Induced Cell Death
520 PD-1 Inhibits Bystander T Cell Activation and Protects from Activation Induced Cell Death
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

520 PD-1 Inhibits Bystander T Cell Activation and Protects from Activation Induced Cell Death

Sheng, Michael ; Le, Catherine ; Dunai, Cordelia ; Lam Khuat ; Vick, Logan ; Stoffel, Kevin ; Monjazeb, Arta ; Collins, Craig ; Canter, Robert ; Murphy, William

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A545-A545 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
7
206 Novel intermediate-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against human hepatocellular carcinoma
206 Novel intermediate-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against human hepatocellular carcinoma
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

206 Novel intermediate-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against human hepatocellular carcinoma

Caraballo-Galva, Leidy ; Jiang, Xiaotao ; Hussein, Mohamed ; Zhang, Huajun ; Mao, Rui ; Brody, Pierce ; Peng, Yibing ; He, AIwu ; Kehinde-Ige, Mercy ; Sadek, Ramses ; Qiu, Xiangguo ; Shi, Huidong ; He, Yukai

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A220-A220 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
8
426 The role of KI-67, P16 and BCL-2 in the management of cervical neoplasia
426 The role of KI-67, P16 and BCL-2 in the management of cervical neoplasia
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

426 The role of KI-67, P16 and BCL-2 in the management of cervical neoplasia

Copos, Anca ; Mocuta, Diana ; Aur, Cristina ; Cuc, Romina

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A16-A16 [Periódico revisado por pares]

Oxford: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
9
Is Irisin Anticancer Agent?
Is Irisin Anticancer Agent?
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Is Irisin Anticancer Agent?

Işıl Yıldırım

Proceedings, 2018, Vol.2 (25), p.1561 [Periódico revisado por pares]

MDPI AG

Texto completo disponível

Citações Citado por
10
The Effect of PTEN on Apoptosis in NSCLC Cell Line
The Effect of PTEN on Apoptosis in NSCLC Cell Line
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

The Effect of PTEN on Apoptosis in NSCLC Cell Line

Aydin Demiray ; Hakan Akca ; Buket Er Urganci

Proceedings, 2018, Vol.2 (25), p.1562 [Periódico revisado por pares]

MDPI AG

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (192)

Data de Publicação 

De até
Refinar
  1. Antes de1999  (30)
  2. 1999Até2004  (64)
  3. 2005Até2010  (179)
  4. 2011Até2017  (106)
  5. Após 2017  (108)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (460)
  2. Francês  (19)
  3. Alemão  (2)
  4. Japonês  (2)
  5. Russo  (1)
  6. Chinês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.